Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Carbohydrate doai
Reexamination Certificate
2011-03-29
2011-03-29
Crane, Lawrence E (Department: 1623)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Carbohydrate doai
C514S046000, C514S047000, C514S048000, C536S026230, C536S026260, C536S026700, C536S027210, C536S027600, C536S027610, C536S027620, C536S027800, C536S027810
Reexamination Certificate
active
07915232
ABSTRACT:
The present invention relates to the use of nucleoside derivatives of formula Iawherein the symbols are as defined in the specification, and of pharmaceutically acceptable salts thereof which inhibit HCV polymerase and are useful for treating a patient suffering from a HCV infection and to pharmaceutical compositions containing such compounds.
REFERENCES:
patent: 3910885 (1975-10-01), Moffatt et al.
patent: 5155112 (1992-10-01), Storer
patent: 5496546 (1996-03-01), Wang
patent: 6333315 (2001-12-01), Ohrui et al.
patent: 6403568 (2002-06-01), Ohrui et al.
patent: 6784166 (2004-08-01), Devos et al.
patent: 7608601 (2009-10-01), Devos et al.
patent: WO98/16184 (1998-04-01), None
Hai et al. (I), Species- or Isozyme-Specific Enzyme Inhibitors. 9. Selective Effects in Inhibitions of Rat Pyruvate Kinase Isozymes by Adenosine 5′-Diphosphate Derivatives, Journal of Medicinal Chemistry, 25(10), 1184-1188 (1982).
Hai et al. (II), Species- or Isozyme-Specific Enzyme Inhibitors. 7. Selective Effects in Inhibitions of Rat Pyruvate Kinase Isozymes by Adenosine 5′-Diphosphate Derivatives, Journal of Medicinal Chemistry, 25(7), 806-812 (1982).
Hans Maag, et al., “Synthesis and Anti-HIV Activity of 4′-Azido- and 4′-Methoxynucleosides1”,Journal of Med. Chem., (1992), pp. 1440-1451, vol. 35.
J. G. Moffatt, outline of the synthesis of 4′-azidocytidine from chapter titled “Chemical Transformations of the Sugar Moiety of Nucleosides,” from bookNucleoside Analogues, (1979) p. 144 published by Plenum Press, New York and London.
Devos Rene Robert
Hobbs Christopher John
Jiang Wen Rong
Martin Joseph Armstrong
Merrett John Herbert
Buckwalter Brian L.
Crane Lawrence E
Roche Palo Alto LLC
LandOfFree
4′-substituted nucleoside derivatives as inhibitors... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with 4′-substituted nucleoside derivatives as inhibitors..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and 4′-substituted nucleoside derivatives as inhibitors... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2665445